Compile Data Set for Download or QSAR
maximum 50k data
Found 83 with Last Name = 'momose' and Initial = 'k'
TargetNeuropeptide Y receptor type 2(RABBIT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM82279(CAS_118997-30-1 | PYY, human)
Affinity DataKi:  2.5nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RABBIT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM82287(NPY2-36 | NPY2-36, human | NPY2-36, porcine)
Affinity DataKi:  4.20nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RABBIT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM82282(NPY13-36 | NPY13-36, porcine)
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RABBIT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM82276(L31,P34-NPY,human | NPY Leu31, Pro34, human, rat |...)
Affinity DataKi:  21nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RABBIT)
Yamanouchi Pharmaceutical

Curated by PDSP Ki Database
LigandPNGBDBM82286(CAS_59763-91-6 | PP, human | PP,SALMON)
Affinity DataKi:  340nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246785((2E,2'E)-N,N'-(Thiodiethane-2,1-diyl)bis[3-(3,4-di...)
Affinity DataIC50:  12nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35353(indole-2-carboxamide derivative, 25e (R-isomer))
Affinity DataIC50:  20nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246632((2E,2'E)-N,N'-Pentane-1,5-diylbis[3-(3,4-dichlorop...)
Affinity DataIC50:  23nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246752((2E,2'E)-N,N'-(Oxydiethane-2,1-diyl)bis[3-(3,4-dic...)
Affinity DataIC50:  26nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246786((2E,2'E)-N,N'-(Sulfinyldiethane-2,1-diyl)bis[3-(3,...)
Affinity DataIC50:  26nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35351(indole-2-carboxamide derivative, 25e)
Affinity DataIC50:  36nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246788((2E,2'E)-N,N'-Butane-1,4-diylbis[3-(3,4-dichloroph...)
Affinity DataIC50:  43nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35350(indole-2-carboxamide derivative, 25d)
Affinity DataIC50:  48nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35349(indole-2-carboxamide derivative, 25c)
Affinity DataIC50:  63nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35345(indole-2-carboxamide derivative, 15)
Affinity DataIC50:  68nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35352(indole-2-carboxamide derivative, 25e (S-isomer))
Affinity DataIC50:  160nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35636(5-chloroindolecarboxamide, 13a)
Affinity DataIC50:  250nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246632((2E,2'E)-N,N'-Pentane-1,5-diylbis[3-(3,4-dichlorop...)
Affinity DataIC50:  260nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246786((2E,2'E)-N,N'-(Sulfinyldiethane-2,1-diyl)bis[3-(3,...)
Affinity DataIC50:  310nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35339(indole-2-carboxamide derivative, 5b)
Affinity DataIC50:  320nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35633(5-chloroindolecarboxamide, 9h)
Affinity DataIC50:  340nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246788((2E,2'E)-N,N'-Butane-1,4-diylbis[3-(3,4-dichloroph...)
Affinity DataIC50:  420nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35628(5-chloroindolecarboxamide, 9c)
Affinity DataIC50:  420nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246752((2E,2'E)-N,N'-(Oxydiethane-2,1-diyl)bis[3-(3,4-dic...)
Affinity DataIC50:  430nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35638(5-chloroindolecarboxamide, 13c)
Affinity DataIC50:  440nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35338(indole-2-carboxamide derivative, 3)
Affinity DataIC50:  440nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246785((2E,2'E)-N,N'-(Thiodiethane-2,1-diyl)bis[3-(3,4-di...)
Affinity DataIC50:  450nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35348(indole-2-carboxamide derivative, 25b)
Affinity DataIC50:  590nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50356025(CHEMBL1911522)
Affinity DataIC50:  780nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35343(indole-2-carboxamide derivative, 9b | trans-isomer...)
Affinity DataIC50:  800nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35347(indole-2-carboxamide derivative, 25a)
Affinity DataIC50:  810nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35341(indole-2-carboxamide derivative, 7)
Affinity DataIC50:  900nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35622(5-chloroindolecarboxamide, 2f)
Affinity DataIC50:  900nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35346((S)-5-chloro-N-(3-(4-fluorophenyl)-1-(4-hydroxypip...)
Affinity DataIC50:  920nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35346((S)-5-chloro-N-(3-(4-fluorophenyl)-1-(4-hydroxypip...)
Affinity DataIC50:  920nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35629(5-chloroindolecarboxamide, 9d)
Affinity DataIC50:  1.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35340(indole-2-carboxamide derivative, 5c)
Affinity DataIC50:  1.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35618(5-chloroindolecarboxamide, 2b)
Affinity DataIC50:  1.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50356029(CHEMBL1911517)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50356019(CHEMBL1911523)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50246787((2E,2'E)-N,N'-(Sulfonyldiethane-2,1-diyl)bis[3-(3,...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35617(5-chloroindolecarboxamide, 2a)
Affinity DataIC50:  1.60E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35635(5-chloroindolecarboxamide, 9j)
Affinity DataIC50:  1.70E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50356031(CHEMBL1911535)
Affinity DataIC50:  1.90E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35634(5-chloroindolecarboxamide, 9i)
Affinity DataIC50:  2.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35630(5-chloroindolecarboxamide, 9e)
Affinity DataIC50:  2.50E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35626(5-chloroindolecarboxamide, 9a)
Affinity DataIC50:  2.60E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50356020(CHEMBL1911524)
Affinity DataIC50:  2.90E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35640(5-chloroindolecarboxamide, 15b)
Affinity DataIC50:  3.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM35627(5-chloroindolecarboxamide, 9b)
Affinity DataIC50:  3.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 83 total ) | Next | Last >>
Jump to: